·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of Aug. 9, 2021

In the news: COVID-19 vaccine boosters, Delta variant surging, CDC recommendations on COVID-19 vaccine for pregnant women, Biden urges Congress to address high drug prices.

Publications & Newsletters
Sign outside of hospital with text indicating admitting and discharge of patients
·
2 Min Read

Give hospital-based doctors access to outpatient formulary info

Without it, cost can lead to medication nonadherence and readmissions. Learn more about new AMA policy to get real-time information to physicians.

Behavioral Health
Hand picking up prescription bottle
·
5 Min Read

4 ways to cut inappropriate antibiotic prescribing

Most hospitals have antibiotic stewardship programs. Learn more with the AMA about what physicians, hospitals can to do improve antibiotic prescribing.

Behavioral Health
·
4 Min Read

Jan. 22, 2021: Judicial Advocacy Update

U.S. Supreme Court: State law can require PBMs to pay fair amount and more in the latest Judicial Advocacy Update.

Advocacy Update
Pharmacy
·
4 Min Read

U.S. Supreme Court: State law can require PBMs to pay fair amount

Physicians asked high court to uphold a state PBM drug-pricing law protecting access to independent and rural pharmacies, and the justices agreed.

Judicial Advocacy
·
2 Min Read

Jan. 8, 2021: Judicial Advocacy Update

Courts block Jan. 1 implementation of most favored nations drug pricing model in the latest judicial Advocacy Update.

Advocacy Update
·
9 Min Read

Dec. 4, 2020: National Advocacy Update 

Administration finalizes drug pricing actions and more in the latest National Advocacy Update.

Advocacy Update
Scale in medical office
·
3 Min Read

COVID-19 exacerbates drug shortages. AMA details next steps.

Analgesics, sedatives among drugs affected by the pandemic. Delegates urge improvements to the global pharmaceutical product supply chain.

Behavioral Health
·
3 Min Read

AMA strengthens policy to combat spike in national drug shortages

Policy outlines a comprehensive framework to address ongoing drug shortages, which have been exacerbated during the COVID-19 pandemic.

Press Releases